Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years

Vaccine

Volumn 25, Issue 39-40, 2007, Pages 6958-6964

  Hammitt, Laura L ^a,b   Hennessy, Thomas W ^a   Fiore, Anthony E ^c   Zanis, Carolyn ^a   Hummel, Kimberlee Boyd ^a   Dunaway, Eitel ^b   Bulkow, Lisa ^a   McMahon, Brian J ^a,d  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d ALASKA NATIVE MEDICAL CENTER   (United States)

Author keywords

Hepatitis B; Hepatitis B virus; Immunogenicity; Vaccine

Indexed keywords

HEPATITIS B ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DATA ANALYSIS; DRUG TOLERABILITY; FEMALE; FEVER; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNOLOGICAL MEMORY; INFECTION PREVENTION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SOMNOLENCE; TREATMENT RESPONSE; UNITED STATES; VACCINATION; VIRUS IMMUNITY;

ADOLESCENT; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; VACCINES, SYNTHETIC;

EID: 34548567080     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.059     Document Type: Article

References (33)

1. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., and Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34 6 (2005) 1329-1339
2. World Health Organization. Hepatitis B vaccines WHO position paper. Available at http://www.who.int/immunization/topics/WHO_position_paper_HepB.pdf. Accessed September 26, 2006.
3. Barrett D., Burks J., McMahon B., Elliott S., Berquist K., Bender T., et al. Epidemiology of hepatitis B in two Alaskan communities. Am J Epidemiol 105 (1977) 118-122
4. Schreeder M., Bender T., McMahon B., Moser M., Murphy B., Sheller M., et al. Prevalence of hepatitis B in selected Alaskan Eskimo villages. Am J Epidemiol 118 (1983) 543-549
5. CDC. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991;40(RR-13):1-25.
6. Armstrong G.L., Mast E.E., Wojczynski M., and Margolis H.S. Childhood hepatitis B virus infections in the United States before hepatitis B immunization. Pediatrics 108 5 (2001) 1123-1128
7. Mast E.E., Margolis H.S., Fiore A.E., Brink E.W., Goldstein S.T., Wang S.A., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 54 RR-16 (2005) 1-31
8. Dentinger C.M., McMahon B.J., Butler J.C., Dunaway C.E., Zanis C.L., Bulkow L.R., et al. Persistence of antibody to hepatitis B and protection from disease among Alaska Natives immunized at birth. Pediatr Infect Dis J 24 9 (2005) 786-792
9. Seto D., West D.J., and Ioli V.A. Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth. Pediatr Infect Dis J 21 8 (2002) 793-795
10. Wainwright R.B., Bulkow L.R., Parkinson A.J., Zanis C., and McMahon B.J. Protection provided by hepatitis B vaccine in a Yupik Eskimo population-results of a 10-year study. J Infect Dis 175 3 (1997) 674-677
11. Williams I.T., Goldstein S.T., Tufa J., Tauillii S., Margolis H.S., and Mahoney F.J. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J 22 2 (2003) 157-163
12. Belloni C., Pistorio A., Tinelli C., Komakec J., Chirico G., Rovelli D., et al. Early immunisation with hepatitis B vaccine: a five-year study. Vaccine 18 14 (2000) 1307
13. Boxall E.H., El-Shuhkri N., Kelly D.A., and Sira J.A. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis 190 7 (2004) 1264-1269
14. Dentinger C, McMahon B, Dunaway C, Zanis C, Bulkow LR, Bruden D, et al. Long-term protection from infant hepatitis B virus vaccination among Alaska Natives. In: Infectious Disease Society of America Annual Meeting, Chicago, IL; 2002. p. 177.
15. Gold Y., Somech R., Mandel D., Peled Y., and Reif S. Decreased immune response to hepatitis B eight years after routine vaccination in Israel. Acta Paediatr 92 10 (2003) 1158-1162
16. Huang L., Chiang B., Lee C., Lee P., Chi W., and Chang M. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology 29 3 (1999) 954-959
17. Patel P, Armstrong GL, Samandari T, Talekar S, Yamaguchi K, Kuhnert W, et al. Long term effectiveness of hepatitis B vaccine in Palau. In: Infectious Disease Society of America Annual Meeting, Boston, MA; 2004.
18. Petersen K.M., Bulkow L.R., McMahon B.J., Zanis C., Getty M., Peters H., et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J 23 7 (2004) 650-655
19. West D.J., and Calandra G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14 11 (1996) 1019
20. Yuen M.F., Lim W.L., Chan A.O., Wong D.K., Sum S.S., and Lai C.L. 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. Clin Gastroenterol Hepatol 2 10 (2004) 941
21. Zanetti A.R., Mariano A., Romano L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366 9494 (2005) 1379
22. Samandari T, Fiore AE, McMahon B, Negus S, Homan C, Williams JL, et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. In: Infectious Disease Society of America Annual Meeting, San Francisco, CA; 2005.
23. American Academy of Pediatrics. Hepatitis B. In: Pickering L.K., Baker C.J., Long S.S., and McMillan J.A. (Eds). Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. (2006), American Academy of Pediatrics, Elk Grove Village, IL 343-344
24. Harpaz R., McMahon B.J., Margolis H.S., Shapiro C.N., Havron D., Carpenter G., et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis 181 2 (2000) 413-418
25. van der Sande M., Waight P., Mendy M., Rayco-Solon P., Hutt P., Fulford T., et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 193 (2006) 1528-1535
26. Shepard C.W., Finelli L., Fiore A.E., and Bell B.P. Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J 24 9 (2005) 755-760
27. Faustini A., Franco E., Sangalli M., Spadea T., Calabrese R.M., Cauletti M., et al. Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy. Vaccine 19 20-22 (2001) 2812-2818
28. CDC. New pediatric formulation of Recombivax HB. MMWR Morb Mortal Wkly Rep 42 35 (1993) 686-687
29. CDC. Notice to readers: FDA approval of change in pediatric formulation for Recombivax HB. MMWR Morb Mortal Wkly Rep 48 2 (1999) 34-35
30. Banatvala J., Van Damme P., and Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 19 (2001) 877-885
31. Hieu N.T., Kim K.H., Janowicz Z., and Timmermans I. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years. Vaccine 20 13-14 (2002) 1803-1808
32. Seto D., West D.J., Gilliam R.R., Ioli V.A., Ferrara D.K., and Rich B. Antibody responses of healthy neonates of two mixed regimens of hepatitis B vaccine. Pediatr Infect Dis J 18 9 (1999) 840-842
33. Public Health Agency of Canada. Canadian immunization guide. Active immunizing agents. 7th ed.; 2006. p. 200. Available at http://www.phac-aspc.gc.ca/publicat/cig-gci/pdf/cig-gci-2006_e.pdf. Accessed May 29, 2007.